Found 23 matching trials
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease EARLY_PHASE1 A Clinical Study on the Safety and Effectiveness of BCMA Chimeric Antigen R...
Show More Learn More & Join Trial
CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma PHASE1 This is a single arm, open-label, single-center, phase 1 study, to determin...
Show More Location
Second Affiliated Hospital of Xi'an Jiaotong University
Learn More & Join Trial
Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL NA At present, there is a lack of relevant research on the first-line treatmen...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults PHASE3 This phase III trial compares the effect of usual treatment of chemotherapy...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites PHASE1 The purpose of this study was to evaluate the efficacy of IFN- Y combined w...
Show More Location
Affiliated Hospital of Jiangnan University
Learn More & Join Trial
CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL PHASE2 Chimeric antigen receptor T-cell (CAR-T) therapy has achieved remarkable ef...
Show More Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus PHASE1 The purpose of the study is to explore the safety and efficacy of cluster o...
Show More Location
Union Hospital Tongji Medical College HUAZHONG University of Science and Technology
Learn More & Join Trial
'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL PHASE1 This is a single-arm open-label phase I/II trial studying the safety and ef...
Show More Location
UT Southwestern Medical Center
Learn More & Join Trial
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease EARLY_PHASE1 A Clinical Study on the Safety and Effectiveness of CD19/BCMA Chimeric Anti...
Show More Learn More & Join Trial
Compassionate Use Re-Infusion of ATLCAR.CD30 N/A This protocol for compassionate use combines 2 different ways of fighting d...
Show More Status
No Longer Available
Location
Lineberger Comprehensive Cancer Center at University of North Carolina
Learn More & Join Trial